Report cover image

Global Oral Nonsteroidal Anti Inflammatory Drugs Market Research Report 2025(Status and Outlook)

Publisher Bosson Research
Published Nov 03, 2025
Length 156 Pages
SKU # BOSS20730169

Description

Report Overview

Nonsteroidal anti-inflammatory drugs (NSAIDs) are medicines that are commonly used for pain relief, stress reduction and high temperature control. They are often used to relieve symptoms of periods of pain, sprains and strains, headaches, cold and flu, arthritis and other long-term pain causes. Non-steroidal medications have sedative and anti-inflammatory effects. Inflammation is caused by the COX-1 and COX-2 enzymes which are inhibited by non-steroidal anti-inflammatory medications (NSAIDs). Some common examples of typical non-steroidal anti-inflammatory medications include aspirin, naproxen, ibuprofen, and paracetamol.

The global Oral Nonsteroidal Anti Inflammatory Drugs market size was estimated at USD 23010.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.40% during the forecast period.

This report provides a deep insight into the global Oral Nonsteroidal Anti Inflammatory Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oral Nonsteroidal Anti Inflammatory Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oral Nonsteroidal Anti Inflammatory Drugs market in any manner.

Global Oral Nonsteroidal Anti Inflammatory Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bayer AG_x000D_

Pfizer Inc_x000D_

Reckitt Benckiser Group PLC_x000D_

Novartis AG_x000D_

DAIICHI SANKYO COMPANY, LIMITED_x000D_

Zydus Group_x000D_

Lupin_x000D_

GSK Plc_x000D_

Glenmark Pharmaceuticals Inc_x000D_

Amneal Pharmaceuticals_x000D_

AstraZeneca_x000D_

Johnson & Johnson

Market Segmentation (by Type)

Penecillins_x000D_

Cephalosporins_x000D_

Tetracyclins_x000D_

Sulfonamides_x000D_

Other

Market Segmentation (by Application)

Sterilization_x000D_

Bacteriostasis

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Oral Nonsteroidal Anti Inflammatory Drugs Market

Overview of the regional outlook of the Oral Nonsteroidal Anti Inflammatory Drugs Market:

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oral Nonsteroidal Anti Inflammatory Drugs Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Oral Nonsteroidal Anti Inflammatory Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Table of Contents

156 Pages
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oral Nonsteroidal Anti Inflammatory Drugs
1.2 Key Market Segments
1.2.1 Oral Nonsteroidal Anti Inflammatory Drugs Segment by Type
1.2.2 Oral Nonsteroidal Anti Inflammatory Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oral Nonsteroidal Anti Inflammatory Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Oral Nonsteroidal Anti Inflammatory Drugs Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Oral Nonsteroidal Anti Inflammatory Drugs Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oral Nonsteroidal Anti Inflammatory Drugs Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Oral Nonsteroidal Anti Inflammatory Drugs Product Life Cycle
3.3 Global Oral Nonsteroidal Anti Inflammatory Drugs Sales by Manufacturers (2020-2025)
3.4 Global Oral Nonsteroidal Anti Inflammatory Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Oral Nonsteroidal Anti Inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oral Nonsteroidal Anti Inflammatory Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Oral Nonsteroidal Anti Inflammatory Drugs Market Competitive Situation and Trends
3.8.1 Oral Nonsteroidal Anti Inflammatory Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oral Nonsteroidal Anti Inflammatory Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Oral Nonsteroidal Anti Inflammatory Drugs Industry Chain Analysis
4.1 Oral Nonsteroidal Anti Inflammatory Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oral Nonsteroidal Anti Inflammatory Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oral Nonsteroidal Anti Inflammatory Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oral Nonsteroidal Anti Inflammatory Drugs Market
5.7 ESG Ratings of Leading Companies
6 Oral Nonsteroidal Anti Inflammatory Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oral Nonsteroidal Anti Inflammatory Drugs Sales Market Share by Type (2020-2025)
6.3 Global Oral Nonsteroidal Anti Inflammatory Drugs Market Size Market Share by Type (2020-2025)
6.4 Global Oral Nonsteroidal Anti Inflammatory Drugs Price by Type (2020-2025)
7 Oral Nonsteroidal Anti Inflammatory Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oral Nonsteroidal Anti Inflammatory Drugs Market Sales by Application (2020-2025)
7.3 Global Oral Nonsteroidal Anti Inflammatory Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Oral Nonsteroidal Anti Inflammatory Drugs Sales Growth Rate by Application (2020-2025)
8 Oral Nonsteroidal Anti Inflammatory Drugs Market Sales by Region
8.1 Global Oral Nonsteroidal Anti Inflammatory Drugs Sales by Region
8.1.1 Global Oral Nonsteroidal Anti Inflammatory Drugs Sales by Region
8.1.2 Global Oral Nonsteroidal Anti Inflammatory Drugs Sales Market Share by Region
8.2 Global Oral Nonsteroidal Anti Inflammatory Drugs Market Size by Region
8.2.1 Global Oral Nonsteroidal Anti Inflammatory Drugs Market Size by Region
8.2.2 Global Oral Nonsteroidal Anti Inflammatory Drugs Market Size Market Share by Region
8.3 North America
8.3.1 North America Oral Nonsteroidal Anti Inflammatory Drugs Sales by Country
8.3.2 North America Oral Nonsteroidal Anti Inflammatory Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oral Nonsteroidal Anti Inflammatory Drugs Sales by Country
8.4.2 Europe Oral Nonsteroidal Anti Inflammatory Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oral Nonsteroidal Anti Inflammatory Drugs Sales by Region
8.5.2 Asia Pacific Oral Nonsteroidal Anti Inflammatory Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oral Nonsteroidal Anti Inflammatory Drugs Sales by Country
8.6.2 South America Oral Nonsteroidal Anti Inflammatory Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oral Nonsteroidal Anti Inflammatory Drugs Sales by Region
8.7.2 Middle East and Africa Oral Nonsteroidal Anti Inflammatory Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Oral Nonsteroidal Anti Inflammatory Drugs Market Production by Region
9.1 Global Production of Oral Nonsteroidal Anti Inflammatory Drugs by Region(2020-2025)
9.2 Global Oral Nonsteroidal Anti Inflammatory Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Oral Nonsteroidal Anti Inflammatory Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oral Nonsteroidal Anti Inflammatory Drugs Production
9.4.1 North America Oral Nonsteroidal Anti Inflammatory Drugs Production Growth Rate (2020-2025)
9.4.2 North America Oral Nonsteroidal Anti Inflammatory Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oral Nonsteroidal Anti Inflammatory Drugs Production
9.5.1 Europe Oral Nonsteroidal Anti Inflammatory Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Oral Nonsteroidal Anti Inflammatory Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oral Nonsteroidal Anti Inflammatory Drugs Production (2020-2025)
9.6.1 Japan Oral Nonsteroidal Anti Inflammatory Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Oral Nonsteroidal Anti Inflammatory Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oral Nonsteroidal Anti Inflammatory Drugs Production (2020-2025)
9.7.1 China Oral Nonsteroidal Anti Inflammatory Drugs Production Growth Rate (2020-2025)
9.7.2 China Oral Nonsteroidal Anti Inflammatory Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Bayer AG_x000D_
10.1.1 Bayer AG_x000D_ Basic Information
10.1.2 Bayer AG_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Overview
10.1.3 Bayer AG_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Market Performance
10.1.4 Bayer AG_x000D_ Business Overview
10.1.5 Bayer AG_x000D_ SWOT Analysis
10.1.6 Bayer AG_x000D_ Recent Developments
10.2 Pfizer Inc_x000D_
10.2.1 Pfizer Inc_x000D_ Basic Information
10.2.2 Pfizer Inc_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Overview
10.2.3 Pfizer Inc_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Market Performance
10.2.4 Pfizer Inc_x000D_ Business Overview
10.2.5 Pfizer Inc_x000D_ SWOT Analysis
10.2.6 Pfizer Inc_x000D_ Recent Developments
10.3 Reckitt Benckiser Group PLC_x000D_
10.3.1 Reckitt Benckiser Group PLC_x000D_ Basic Information
10.3.2 Reckitt Benckiser Group PLC_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Overview
10.3.3 Reckitt Benckiser Group PLC_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Market Performance
10.3.4 Reckitt Benckiser Group PLC_x000D_ Business Overview
10.3.5 Reckitt Benckiser Group PLC_x000D_ SWOT Analysis
10.3.6 Reckitt Benckiser Group PLC_x000D_ Recent Developments
10.4 Novartis AG_x000D_
10.4.1 Novartis AG_x000D_ Basic Information
10.4.2 Novartis AG_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Overview
10.4.3 Novartis AG_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Market Performance
10.4.4 Novartis AG_x000D_ Business Overview
10.4.5 Novartis AG_x000D_ Recent Developments
10.5 DAIICHI SANKYO COMPANY, LIMITED_x000D_
10.5.1 DAIICHI SANKYO COMPANY, LIMITED_x000D_ Basic Information
10.5.2 DAIICHI SANKYO COMPANY, LIMITED_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Overview
10.5.3 DAIICHI SANKYO COMPANY, LIMITED_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Market Performance
10.5.4 DAIICHI SANKYO COMPANY, LIMITED_x000D_ Business Overview
10.5.5 DAIICHI SANKYO COMPANY, LIMITED_x000D_ Recent Developments
10.6 Zydus Group_x000D_
10.6.1 Zydus Group_x000D_ Basic Information
10.6.2 Zydus Group_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Overview
10.6.3 Zydus Group_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Market Performance
10.6.4 Zydus Group_x000D_ Business Overview
10.6.5 Zydus Group_x000D_ Recent Developments
10.7 Lupin_x000D_
10.7.1 Lupin_x000D_ Basic Information
10.7.2 Lupin_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Overview
10.7.3 Lupin_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Market Performance
10.7.4 Lupin_x000D_ Business Overview
10.7.5 Lupin_x000D_ Recent Developments
10.8 GSK Plc_x000D_
10.8.1 GSK Plc_x000D_ Basic Information
10.8.2 GSK Plc_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Overview
10.8.3 GSK Plc_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Market Performance
10.8.4 GSK Plc_x000D_ Business Overview
10.8.5 GSK Plc_x000D_ Recent Developments
10.9 Glenmark Pharmaceuticals Inc_x000D_
10.9.1 Glenmark Pharmaceuticals Inc_x000D_ Basic Information
10.9.2 Glenmark Pharmaceuticals Inc_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Overview
10.9.3 Glenmark Pharmaceuticals Inc_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Market Performance
10.9.4 Glenmark Pharmaceuticals Inc_x000D_ Business Overview
10.9.5 Glenmark Pharmaceuticals Inc_x000D_ Recent Developments
10.10 Amneal Pharmaceuticals_x000D_
10.10.1 Amneal Pharmaceuticals_x000D_ Basic Information
10.10.2 Amneal Pharmaceuticals_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Overview
10.10.3 Amneal Pharmaceuticals_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Market Performance
10.10.4 Amneal Pharmaceuticals_x000D_ Business Overview
10.10.5 Amneal Pharmaceuticals_x000D_ Recent Developments
10.11 AstraZeneca_x000D_
10.11.1 AstraZeneca_x000D_ Basic Information
10.11.2 AstraZeneca_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Overview
10.11.3 AstraZeneca_x000D_ Oral Nonsteroidal Anti Inflammatory Drugs Product Market Performance
10.11.4 AstraZeneca_x000D_ Business Overview
10.11.5 AstraZeneca_x000D_ Recent Developments
10.12 Johnson and Johnson
10.12.1 Johnson and Johnson Basic Information
10.12.2 Johnson and Johnson Oral Nonsteroidal Anti Inflammatory Drugs Product Overview
10.12.3 Johnson and Johnson Oral Nonsteroidal Anti Inflammatory Drugs Product Market Performance
10.12.4 Johnson and Johnson Business Overview
10.12.5 Johnson and Johnson Recent Developments
11 Oral Nonsteroidal Anti Inflammatory Drugs Market Forecast by Region
11.1 Global Oral Nonsteroidal Anti Inflammatory Drugs Market Size Forecast
11.2 Global Oral Nonsteroidal Anti Inflammatory Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oral Nonsteroidal Anti Inflammatory Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Oral Nonsteroidal Anti Inflammatory Drugs Market Size Forecast by Region
11.2.4 South America Oral Nonsteroidal Anti Inflammatory Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oral Nonsteroidal Anti Inflammatory Drugs by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Oral Nonsteroidal Anti Inflammatory Drugs Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Oral Nonsteroidal Anti Inflammatory Drugs by Type (2026-2033)
12.1.2 Global Oral Nonsteroidal Anti Inflammatory Drugs Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Oral Nonsteroidal Anti Inflammatory Drugs by Type (2026-2033)
12.2 Global Oral Nonsteroidal Anti Inflammatory Drugs Market Forecast by Application (2026-2033)
12.2.1 Global Oral Nonsteroidal Anti Inflammatory Drugs Sales (K MT) Forecast by Application
12.2.2 Global Oral Nonsteroidal Anti Inflammatory Drugs Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.